Johnson & Johnson
NYSE: JNJ
$162.81
-$0.18 (-0.1%)
Closing Price on March 14, 2025
JNJ Articles
Reuters: China celebrated 60 years of communist rule as a capitalist economy. Reuters: The IMF cut global debt write-offs to $3.4 trillion. Reuters: CIT (CIT) is close to a deal to give...
Published:
Last Updated:
Reuters: Solvay sold its drug unit to Abbott (ABT) foe $6.6 billion. Reuters: Kraft (KFT) will launch a hostile bid for Cadbury. Reuters: The World Bank said not to take the dollar’s...
Published:
Last Updated:
Reuters: Obama is trying to push Wall St. reform. Reuters: German aid for Opel will go in part to Russia for operations there. Reuters: A global poll shows support for stimulus packages....
Published:
Last Updated:
Several consulting firms post annual figures for the world’s most valuable brands. The two best known are probably the Interbrand and BrandZ surveys. They are notably different, up until now at...
Published:
Last Updated:
Now that we are out of the woods in the crash scenario, assuming this week is no ill omen, investors may want to know which of the big companies would start to deploy their billions and billions of...
Published:
Last Updated:
Wasn’t it just last week that we were up eight days in a row on the DJIA? And now we have a sell-the-news reaction to the recent growth numbers. Maybe it is because we ran too far too fast and...
Published:
Last Updated:
Reuters: UBS (UBS) shares may fall when the Swiss government sells out. Reuters: The US deficit estimate was trimmed to $1.59 trillion. Reuters: A homeowner sued Wells Fargo (WFC) over a...
Published:
Last Updated:
Berkshire Hathaway Inc. (NYSE: BRK-A)(BRK-B) has released its Q2-2009 public equity holdings as of June 30, 2009. There are some portfolio changes that have been seen here from the end of Q1 and...
Published:
Last Updated:
Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get a great deal beyond the cancer monoclonal antibody that developed together. The...
Published:
Last Updated:
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Published:
Last Updated:
Reuters: The US may give CIT (CIT) short term loans. Reuters: Intel (INTC) issued a positive forecast and indicated that the PC market may be improving. Reuters: The US CPI was up more...
Published:
Last Updated:
DJIA component Johnson & Johnson (NYSE: JNJ) has come out with earnings slightly ahead of estimates. The medical and consumer products giant posted $1.15 EPS vs $1.11 estimates and revenues...
Published:
Reuters: Smart investors are starting to cherry- pick stocks. Reuters: California may agree on a budget to stop using IOUs. Reuters: Some stock funds are still making up for lost ground....
Published:
Last Updated:
Reuters: Cybercrime is spreading fast on Facebook. Reuters: GM will seek to sell most of its assets to a new company. Reuters: Madoff got 150 years in prison. Reuters: AIG (AIG)...
Published:
Last Updated:
Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma today suggests half of the top 100 drugs worldwide by 2014 –...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.